EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Global, regional, and national disease burden of multidrug-resistant tuberculosis without extensive drug resistance, 1990–2021: Findings from the Global Burden of Disease Study 2021

Xinyue Wang, Anquan Shang, Haowei Chen, Jing Li, Yuan Jiang, Lili Wang, Shuai Qiu, Fenyong Sun, Chaoyan Yue

Drug Resistance Updates · 2025-09 · 82 · 101265

DOI: 10.1016/j.drup.2025.101265 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Resistance Updates, 2025-09. Verfasst von Xinyue Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory Medicine, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai 200072, PR China. Hauptthemen laut MEDLINE: Tuberculosis, Multidrug-Resistant, Global Burden of Disease. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Shanghai Municipal Health Commission, National Natural Science Foundation of China, Jiangsu Commission of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: Utilizing Global Burden of Disease Study (GBD 2021) data, this study aims to illustrate trends and spatiotemporal patterns of multidrug-resistant tuberculosis (MDR-TB) burden from 1990 to 2021, and explore their potential mechanisms. METHODS: This research extracted core indicators including incidence, mortality, prevalence, and disability-adjusted life years (DALYs), with their age-standardized rate (ASR). Joinpoint regression, age-period-cohort analysis, inequality analysis, and frontier analysis were applied to describe the temporal and spatial trends of the disease burden. Decomposition analysis and risk factor analysis were performed to explore factors associated with MDR-TB burden fluctuation. Bayesian Age-Period-Cohort (BAPC) model was used to project the disease burden till 2050. RESULTS: Global MDR-TB cases and ASRs of all indicators rose from 1990 to 2021, with heavier burden in older populations and lower socioeconomic regions. Cross-country inequality widened over time. Frontier analysis identified countries including India and Russia with considerable potential for improvement in disease control. Decomposition analysis uncovered epidemiological changes as the main driver of the growing burden globally. Risk factors of MDR-TB in different regions and age groups were heterogeneous. The numbers and ASRs of all indicators are predicted to increase by 2050. CONCLUSIONS: This study revealed that the global disease burden of MDR-TB increased from 1990 to 2021 and is predicted to grow till 2050. Disparities among different social-demographic regions were remarkable and extended over time. Epidemiological changes contributed most to the escalated disease burden. Targeted public health strategies should be adopted for patients in specific regions and age groups.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tuberculosis, Multidrug-ResistantGlobal Burden of DiseaseHumansAdultMaleRisk FactorsPrevalenceIncidenceGlobal HealthFemaleDisability-Adjusted Life YearsMiddle AgedAntitubercular AgentsYoung AdultAdolescentBayes TheoremAged

Stichwörter der Autor:innen

Global Burden of DiseaseInequalityMDR-TBRisk factor

Substanzen

Antitubercular Agents

Autor:innen und Institutionen

  • Department of Clinical Laboratory Medicine, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai 200072, PR China.
  • Department of Laboratory Medicine, The Second People's Hospital of Lianyungang, Clinical College of Xuzhou Medical University, Lianyungang 222006, PR China.
  • Clinical Research Centre, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong 510280, PR China.
  • Division of TB and HIV/AlDS Prevention, Shanghai Municipal Center for Disease Control and Prevention, Shanghai, PR China.
  • Department of Clinical Laboratory Medicine, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai 200072, PR China. Electronic address: qsly2022@163.com.
  • Department of Clinical Laboratory Medicine, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai 200072, PR China; Department of Clinical Laboratory, Shanghai Tenth People's Hospital, School…

Förderung

  • Shanghai Municipal Health Commission
  • National Natural Science Foundation of China
  • Jiangsu Commission of Health
  • Shanghai Municipal Health Bureau
  • Science and Technology Innovation Plan Of Shanghai Science and Technology Commission

Zitieren

APA

Wang, X., Shang, A., Chen, H., Li, J., Jiang, Y., Wang, L., Qiu, S., Sun, F., & Yue, C. (2025). Global, regional, and national disease burden of multidrug-resistant tuberculosis without extensive drug resistance, 1990–2021: Findings from the Global Burden of Disease Study 2021. Drug Resistance Updates, 82, 101265. https://doi.org/10.1016/j.drup.2025.101265

Vancouver

Wang X, Shang A, Chen H, Li J, Jiang Y, Wang L, et al. Global, regional, and national disease burden of multidrug-resistant tuberculosis without extensive drug resistance, 1990–2021: Findings from the Global Burden of Disease Study 2021. Drug Resistance Updates. 2025;82:101265. doi:10.1016/j.drup.2025.101265

BibTeX
@article{Wang2025,
  author = {Wang, Xinyue and Shang, Anquan and Chen, Haowei and Li, Jing and Jiang, Yuan and Wang, Lili and Qiu, Shuai and Sun, Fenyong and Yue, Chaoyan},
  title = {Global, regional, and national disease burden of multidrug-resistant tuberculosis without extensive drug resistance, 1990–2021: Findings from the Global Burden of Disease Study 2021},
  journal = {Drug Resistance Updates},
  year = {2025},
  volume = {82},
  pages = {101265},
  doi = {10.1016/j.drup.2025.101265}
}
Kostenlos starten →